Loading company…
Kyoto-based supplier of immature blood cells and evaluation services for testing drugs and functional materials.
Based in Kyoto, Japan, and established in 2016, MiCAN Technologies supplies immature blood cell products for research, including Mpv and Mylc cells, and sells kits with the items needed for evaluation. It also offers contract services for efficacy evaluation and safety evaluation, including skin sensitization assay and pyrogen test. In 2019 it raised JPY 127 million from third-party share allocations, including Osaka University Venture Capital Co., Ltd.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in